Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00430
|
|||||
| Drug Name |
Fentanyl
|
|||||
| Synonyms |
Abstral; Actiq; Duragesic-100; Duragesic-12; Duragesic-25; Duragesic-50; Duragesic-75; Fentanyl; Fentanyl Citrate; Fentanyl Citrate Preservative Free; Fentanyl-100; Fentanyl-12; Fentanyl-25; Fentanyl-37; Fentanyl-50; Fentanyl-62; Fentanyl-75; Fentanyl-87; Fentora; Lazanda; Onsolis; Sublimaze Preservative Free; Subsys
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Analgesia [ICD11: MB40.8] | Approved | [1] | |||
| Therapeutic Class |
Neurology Agents
|
|||||
| Structure |
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H28N2O
|
|||||
| Canonical SMILES |
CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
|
|||||
| InChI |
InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3
|
|||||
| InChIKey |
PJMPHNIQZUBGLI-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 437-38-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 336.5 | Topological Polar Surface Area | 23.6 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:119915
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Fentanyl was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
